Zydus Wellness · NSE: ZYDUSWELL · BSE: 531335
Q4 FY24 results · Jan–Mar 2024
Zydus Wellness reported revenue from operations of ₹782.60 crore (up 9.8% from Q4 FY23) and net profit of ₹150.30 crore (up 3.4% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 782.60 | 712.98 | +9.8% | 403.20 | +94.1% |
| Other income | 4.00 | 0.72 | +455.6% | 3.40 | +17.6% |
| Total income | 786.60 | 713.70 | +10.2% | 406.60 | +93.5% |
| Profit before tax | 154.40 | 126.33 | +22.2% | 3.70 | 42x |
| Net profit for the period | 150.30 | 145.33 | +3.4% | 0.30 | 501x |
| EPS, basic (₹) | 23.62 | 22.84 | +3.4% | 0.05 | 472x |
| Net margin (%) | 19.2 | 20.4 | 0.1 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 63.10 | 58.74 | +7.4% | 63.80 | −1.1% |
| Other income | 4.70 | 3.58 | +31.3% | 4.60 | +2.2% |
| Total income | 67.80 | 62.32 | +8.8% | 68.40 | −0.9% |
| Profit before tax | 10.40 | 10.51 | −1.0% | 13.60 | −23.5% |
| Net profit for the period | 7.40 | 28.66 | −74.2% | 10.30 | −28.2% |
| EPS, basic (₹) | 1.16 | 4.50 | −74.2% | 1.62 | −28.4% |
| Net margin (%) | 11.7 | 48.8 | 16.1 |
Consolidated
- Filed with BSE
- 15 May 2024, 09:46 IST
- Board meeting
- 14 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 15 May 2024, 09:46 IST
- Board meeting
- 14 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE